Biopharmaceutical Outsourcing Market 2028 By Service | The Insight Partners

Biopharmaceutical Outsourcing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Service (Clinical Trials, Drug Discovery, API Development, Contract Production and Packaging, Non-Clinical Services, Others)

Report Code: TIPRE00018822 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biopharmaceutical Outsourcing Market - By Service
1.3.2 Biopharmaceutical Outsourcing Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOPHARMACEUTICAL OUTSOURCING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOPHARMACEUTICAL OUTSOURCING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOPHARMACEUTICAL OUTSOURCING MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOPHARMACEUTICAL OUTSOURCING - GLOBAL MARKET OVERVIEW
6.2. BIOPHARMACEUTICAL OUTSOURCING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOPHARMACEUTICAL OUTSOURCING MARKET - REVENUE AND FORECASTS TO 2028 - SERVICE
7.1. OVERVIEW
7.2. SERVICE MARKET FORECASTS AND ANALYSIS
7.3. CLINICAL TRIALS
7.3.1. Overview
7.3.2. Clinical Trials Market Forecast and Analysis
7.4. DRUG DISCOVERY
7.4.1. Overview
7.4.2. Drug Discovery Market Forecast and Analysis
7.5. API DEVELOPMENT
7.5.1. Overview
7.5.2. API Development Market Forecast and Analysis
7.6. CONTRACT PRODUCTION AND PACKAGING
7.6.1. Overview
7.6.2. Contract Production and Packaging Market Forecast and Analysis
7.7. NON-CLINICAL SERVICES
7.7.1. Overview
7.7.2. Non-Clinical Services Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. BIOPHARMACEUTICAL OUTSOURCING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Biopharmaceutical Outsourcing Market Overview
8.1.2 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.1.3 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.1.4 North America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.1.4.1 United States Biopharmaceutical Outsourcing Market
8.1.4.1.1 United States Biopharmaceutical Outsourcing Market by Service
8.1.4.2 Canada Biopharmaceutical Outsourcing Market
8.1.4.2.1 Canada Biopharmaceutical Outsourcing Market by Service
8.1.4.3 Mexico Biopharmaceutical Outsourcing Market
8.1.4.3.1 Mexico Biopharmaceutical Outsourcing Market by Service
8.2. EUROPE
8.2.1 Europe Biopharmaceutical Outsourcing Market Overview
8.2.2 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.2.3 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.2.4 Europe Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Biopharmaceutical Outsourcing Market
8.2.4.1.1 Germany Biopharmaceutical Outsourcing Market by Service
8.2.4.2 France Biopharmaceutical Outsourcing Market
8.2.4.2.1 France Biopharmaceutical Outsourcing Market by Service
8.2.4.3 Italy Biopharmaceutical Outsourcing Market
8.2.4.3.1 Italy Biopharmaceutical Outsourcing Market by Service
8.2.4.4 Spain Biopharmaceutical Outsourcing Market
8.2.4.4.1 Spain Biopharmaceutical Outsourcing Market by Service
8.2.4.5 United Kingdom Biopharmaceutical Outsourcing Market
8.2.4.5.1 United Kingdom Biopharmaceutical Outsourcing Market by Service
8.2.4.6 Rest of Europe Biopharmaceutical Outsourcing Market
8.2.4.6.1 Rest of Europe Biopharmaceutical Outsourcing Market by Service
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Biopharmaceutical Outsourcing Market Overview
8.3.2 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.3.3 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.3.4 Asia-Pacific Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Biopharmaceutical Outsourcing Market
8.3.4.1.1 Australia Biopharmaceutical Outsourcing Market by Service
8.3.4.2 China Biopharmaceutical Outsourcing Market
8.3.4.2.1 China Biopharmaceutical Outsourcing Market by Service
8.3.4.3 India Biopharmaceutical Outsourcing Market
8.3.4.3.1 India Biopharmaceutical Outsourcing Market by Service
8.3.4.4 Japan Biopharmaceutical Outsourcing Market
8.3.4.4.1 Japan Biopharmaceutical Outsourcing Market by Service
8.3.4.5 South Korea Biopharmaceutical Outsourcing Market
8.3.4.5.1 South Korea Biopharmaceutical Outsourcing Market by Service
8.3.4.6 Rest of Asia-Pacific Biopharmaceutical Outsourcing Market
8.3.4.6.1 Rest of Asia-Pacific Biopharmaceutical Outsourcing Market by Service
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Biopharmaceutical Outsourcing Market Overview
8.4.2 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.4.3 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.4.4 Middle East and Africa Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Biopharmaceutical Outsourcing Market
8.4.4.1.1 South Africa Biopharmaceutical Outsourcing Market by Service
8.4.4.2 Saudi Arabia Biopharmaceutical Outsourcing Market
8.4.4.2.1 Saudi Arabia Biopharmaceutical Outsourcing Market by Service
8.4.4.3 U.A.E Biopharmaceutical Outsourcing Market
8.4.4.3.1 U.A.E Biopharmaceutical Outsourcing Market by Service
8.4.4.4 Rest of Middle East and Africa Biopharmaceutical Outsourcing Market
8.4.4.4.1 Rest of Middle East and Africa Biopharmaceutical Outsourcing Market by Service
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Biopharmaceutical Outsourcing Market Overview
8.5.2 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis
8.5.3 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Service
8.5.4 South and Central America Biopharmaceutical Outsourcing Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Biopharmaceutical Outsourcing Market
8.5.4.1.1 Brazil Biopharmaceutical Outsourcing Market by Service
8.5.4.2 Argentina Biopharmaceutical Outsourcing Market
8.5.4.2.1 Argentina Biopharmaceutical Outsourcing Market by Service
8.5.4.3 Rest of South and Central America Biopharmaceutical Outsourcing Market
8.5.4.3.1 Rest of South and Central America Biopharmaceutical Outsourcing Market by Service
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOPHARMACEUTICAL OUTSOURCING MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. BIOPHARMACEUTICAL OUTSOURCING MARKET, KEY COMPANY PROFILES
11.1. SARTORIUS AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. EMCURE PHARMACEUTICALS LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOPHARMA SERVICES INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LAMBDA THERAPEUTIC RESEARCH LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BAXTER HEALTHCARE CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. KEYRUS BIOPHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. QUINTILES INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. APTUIT LLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. KBI BIOPHARM
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ICON PLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. SARTORIUS AG
2. EMCURE PHARMACEUTICALS LTD
3. BIOPHARMA SERVICES INC.
4. LAMBDA THERAPEUTIC RESEARCH LTD.
5. BAXTER HEALTHCARE CORPORATION
6. KEYRUS BIOPHARMA
7. QUINTILES INC.
8. APTUIT LLC
9. KBI BIOPHARM
10. ICON PLC
TIPRE00018822
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount